Skip to main content
16/06/2015

Dr. Israel Molina wins ex aquo the Prize Young Researcher from ICS

2015_0109_IMATGE

16/06/2015

The researcher in Infectious Diseases from VHIR received the award in the 7th Research Day of ICS

Dr. Israel Molina, from the research group in Infectious Diseases at Vall d’Hebron Research Institute (VHIR) and head of the International Health Program of the Institut Català de Salut (PROSICS), has wan ex aequo the Prize Young Researcher from ICS. The recognition was received at the "https://infoicscat.wordpress.com/2015/06/15/la-7a-jornada-de-recerca-de-lics-aborda-la-resistencia-als-antibiotics-com-un-dels-principals-problemes-del-tractament-de-les-malalties-infeccioses/" 7th Research Day of ICS, this year dedicated to infectious diseases.Dr. Molina (Barcelona, 1974) is a doctor specialized in intern medicine and, now, heads at the VHIR and at the PROSICS various research projects. Among them the European project Berenice stands out, which is looking for a more efficient and less toxic medicine for Chagas disease using nanotechnology. He has been working in Africa (Angola) many times and he has built up a strong relationship with the Hospital Nostra Senhora da Paz de Cubal. He has also been working on Brazil, thanks to a grant, and has done many different studies in collaboration with other tropical medicine research institutes. The same award was given to Dr. Oriol Bestard from the Institut d’Investigació Biomèdica de Bellvitge (IDIBELL). The same day, Dr. Francesc Gudiol, director of the program Monitoring Nosocomial Infections in Catalan Hospitals (VINCAT) from the Health Department and researcher from IDIBELL received an award for his scientific trajectory.7th Research Day of ICS250 researchers from 7 research institutes related to hospitals or primary health care centers talked about the newest scientific achievements in the field of infectious diseases. Dr. Benito Almirante, head of the research group in Infectious Diseases at VHIR, moderated a panel session on bacterial resistance, where Dr. Maria Nieves Larrossa, researcher from the group of Microbiology at VHIR, participated. The main points of the Day were, first, the advances intended to have faster methodology for the diagnosis of the antibiotics’ resistance and sensibility (to be able to choose the best antibiotic in each case) and the review of the most important problems caused by antibiotics’ resistance. In the other hand, the Day was also focused on the use of antibacterial medicines in primary health care centers and the transversal programs for the good use of the antibiotics that are prepared for Hospitals.

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.